Affecting 200 million women of reproductive age, endometriosis is a chronic inflammatory disease that causes pain, infertility, and increased ovarian cancer risk. Hormone therapies are often used to manage pain and prevent the growth of uterine-lining-like tissue outside of the uterus, but these therapies can be ineffective and lead to recurrence. In a new study, published by Wiley in Advanced Science , researchers identified TREM2 + macrophages as a potential future target for endometriosis therapies.
The immune system has been implicated in endometriosis progression. Highly abundant and promoting harmful growth during endometriosis, macrophages are immune cells that destroy infections, cancer, and cellular debris and modulate the adaptive immune system, which is a strong line of defense remembering past invaders. Members of the immune system shown to be dysfunctional in endometriosis are CD8 + T cells and natural killer (NK) cells. While macrophages have been suggested to impair CD8 + T cells and NK cells in disease progression, how they drive these defects in the adaptive immune system remained unclear.
Using single-cell RNA sequencing of endometriosis patient samples, researchers found an enrichment of macrophages expressing the receptor TREM2 compared to control samples. They also found that CD8 + T cells and NK cells in endometriosis samples were terminally exhausted and had reduced ability to kill damaged or foreign cells. The authors hypothesized that TREM2 + macrophages compromise CD8 + T cells and NK cells, which they validated by culturing CD8 + T cells and NK cells with macrophages with and without TREM2 from mice.
The researchers identified the ligand-receptor pair by which TREM2 + macrophages and CD8 + T cells could be communicating. Further, the cellular recycling process called autophagy was connected to CD8 + T cell dysfunction downstream of TREM2 + macrophages. Finally, the scientists tested these findings in mice, showing that mice without TREM2 increased CD8 + T cell and NK cell cytotoxic behavior and protected against endometrium growth.
In this study, the researchers discovered that TREM2 + macrophages disrupt the adaptive immune system in endometriosis, contributing to disease progression. These results point to TREM2 as a potential therapeutic target, though the safety of TREM2 inhibition in general immune regulation and specifically in reproductive tissues require further evaluation. In addition, larger cohort sizes of patient samples should be used for validation of these findings.
“Our research reveals that a specific subset of macrophages contributes to immune dysfunction in endometriosis by suppressing the activity of cytotoxic immune cells. These findings provide new insights into disease progression and may open new avenues for developing non-hormonal therapies. However, further research is needed before these findings can be translated into clinical practice,” said senior author Guoyun Wang, PhD of the Shandong Provincial Hospital Affiliated to Shandong First Medical University in China.
Additional information
NOTE: The information contained in this release is protected by copyright. Please include journal attribution in all coverage. For more information or to obtain a PDF of any study, please contact: Sara Henning-Stout, newsroom@wiley.com
Full Citation:
“TREM2 + macrophages promote immune evasion in endometriosis through BAG3-associated regulation of CD8 + T cell autophagy.” Ming Yuan, Xue Jiao, Le Xu, Qianhui Ren, Shuang Wang, Zhaoyang Zhong, Na Li, Qiuju Li, Xiaoli Meng, and Guoyun Wang. Advanced Science ; Published Online: November 12, 2026 (DOI: 10.1002/78385).
URL Upon Publication : http://doi.wiley.com/10.1002/advs.78385
Author Contact: Corresponding author Guoyun Wang at wangguoy@sdu.edu.cn
About the Journal
Advanced Science is a premier interdisciplinary open access journal covering fundamental and applied research across a broad range of fields, including materials science and chemistry, physics and engineering, life and health sciences, earth and environmental sciences, as well as social sciences and humanities. Advanced Science publishes cutting-edge research through a rigorous, efficient, and fair review process, ensuring fast publication with high-quality standards and an exceptional author experience. Advanced Science is the flagship journal of Wiley’s Advanced Portfolio : a family of globally respected, high-impact journals that disseminate the best science from well-established and emerging researchers so they can fulfill their mission and maximize the reach of their scientific discoveries.
About Wiley
Wiley is a global leader in authoritative content and research intelligence for the advancement of scientific discovery, innovation, and learning. With more than 200 years at the center of the scholarly ecosystem, Wiley combines trusted publishing heritage with AI-powered platforms to transform how knowledge is discovered, accessed, and applied. From individual researchers and students to Fortune 500 R&D teams, Wiley enables the transformation of scientific breakthroughs into real-world impact. From knowledge to impact—Wiley is redefining what's possible in science and learning. Visit us at Wiley.com and Investors.Wiley.com . Follow us on Facebook , X , LinkedIn and Instagram .
Advanced Science
TREM2+ macrophages promote immune evasion in endometriosis through BAG3-associated regulation of CD8+ T cell autophagy
12-Nov-2026